Vegfr Tki (Clinical Trials) Equipment
1 equipment items found
-
Manufactured by AVEO Pharmaceuticals, Inc.based in USA
FOTIVDA (tivozanib) is an oral, once-daily, differentiated vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitor (TKI). It is a potent, selective inhibitor of VEGFRs 1, 2, and 3 with a long half-life designed to improve efficacy and tolerability.1,2 AVEO received U.S. Food and Drug Administration (FDA) approval for ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you